Category Archives: Inducement to Infringe

Allied Mineral Products, Inc. v. OSMI, Inc. et al. (“Stellar”)

Docket No. 2016-2641 MOORE, REYNA, STOLL September 13, 2017 Brief summary: DC dismissal for lack of subject matter jurisdiction since Stellar only took action against Allied’s distributors in MX but no action against Allied (in MX or the US). Summary: … Continue reading

Posted in Article III disputes, Contributory Infringement, Inducement to Infringe, Infringement | Leave a comment

Lifetime Industries, Inv. V. Trim-Lok, Inc.

2017-1096 LOURIE, MOORE, O’MALLEY September 7, 2017 Brief summary: DC grant of Trim-Lok’s motion to dismiss Lifetime’s infringement complaint reversed and remanded since, e.g., LT adequately “alleged that an agent of Trim-Lok installed the seal onto the RV”. Summary: Lifetime … Continue reading

Posted in Contributory Infringement, Inducement to Infringe, Infringement | Leave a comment

The Cleveland Clinic Foundation et al. v. True Health Diagnostics LLC

Docket No. 2016-1766 LOURIE, REYNA, WALLACH June 16, 2017 Brief Summary: Patent directed at detecting myeloperoxidase release as a sign of cardiovascular disease ineligible under § 101. DC decision of no contributory or induced infringement affirmed since CCF fell “short … Continue reading

Posted in Contributory Infringement, Inducement to Infringe, Infringement, Patentability, Uncategorized | Leave a comment

Rivera et al. v. International Trade Commission and Solofill, LLC (Intervenor)

Docket No. 2016-1841 REYNA, LINN, CHEN May 23, 2017 Brief Summary: ITC decision of no § 337 violation because the asserted claims to a beverage brewer are invalid for lack of written description affirmed. Summary: Rivera appealed ITC holding that … Continue reading

Posted in Contributory Infringement, Importation, Inducement to Infringe, Infringement, International Trade Commission, Written description | Leave a comment

Braintree Laboratories, Inc. v. Breckenridge Pharmaceutical, Inc.

Docket No. 2016-1731 NEWMAN, MOORE, WALLACH May 5, 2017 Non-precedential Brief Summary: DC claim construction (e.g., previous Novel decision “foreclosed the [DC’s] construction of ‘from about 100 ml to about 500 ml’”) and infringement decisions reversed (e.g., claimed effects of … Continue reading

Posted in Claim Construction, Generics / ANDA, Inducement to Infringe, Infringement | Leave a comment

Tinnus Enterprises, LLC et al. v. Telebrands Corp. et al.

Docket No. 2016-1410 MOORE, WALLACH, STOLL January 24, 2017 Brief Summary: DC grant of PI and no invalidity for indefiniteness or obviousness affirmed. Summary: Telebrands appealed DC entry of preliminary injunction (PI) barring it from selling its “Balloon Bonanza, or … Continue reading

Posted in Analgous Art, Indefiniteness, Inducement to Infringe, Infringement, Obviousness | Leave a comment

Eli Lilly and Company v. Teva Parenteral Medicines, Inc. et al.

Docket No. 2015-2067 REYNA, HUGHES, STOLL January 12, 2017 Brief Summary: DC decision finding of direct infringement by physicians and induced infringement (§ 271(b)) by Teva as well as no obviousness affirmed. Summary: Teva et al. (“Teva”) appealed DC finding … Continue reading

Posted in Claim Differentiation, Indefiniteness, Inducement to Infringe, Infringement, Obviousness | Leave a comment